drugset / Trial / NCT00237159
Effect of Zoledronic Acid in Patients With Prostate Cancer and Bone Metastasis
Non-randomizedSingle-groupOpen-labelTreatment
Summary
It is the aim of this clinical study to evaluate the skeletal-related event rate and tolerability of zoledronic acid in patients with prostate cancer patients and bone metastases.
Timeline
- Start
- 2002-10
- Primary completion
- 2005-12
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Zoledronic acid | Other / unclassified | — | — |